BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,518.90
- Market cap
- ₹42,672 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.0×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals has issued a Postal Ballot notice for shareholder approval. The resolutions involve appointing Karine J F Natland and re-appointing Bhushan Akshikar as Managing Director.
Other board meeting date announcements
All →Consecutive Commodities Board Meeting Date
Consecutive Commodities will hold a board meeting on 3 November 2026 to consider unaudited quarterly and half-year results. Agenda items are proposed only, not yet approved.
Radhika Jeweltech Board Meeting Date
Radhika Jeweltech will hold a board meeting on November 3, 2026 to consider unaudited quarterly results. The trading window reopens 48 hours after results are declared.
Technopack Polymers Board Meeting Date
Technopack Polymers will hold a board meeting on 4 November 2026 to consider unaudited standalone results for the half year ended 30 September 2026. Trading window closes from 1 October 2026 until 48 hours after the results are made public.
Shlokka Dyes Board Meeting Date
Shlokka Dyes scheduled a board meeting for November 3, 2026 to consider half-year results and fund-raising. Agenda items are proposed and subject to approvals.
Trom Industries Board Meeting Date
TROM Industries Limited has scheduled a board meeting on 03-Nov-2026 to consider unaudited half-yearly standalone results for the period ended September 2026. The trading window closes from 01-Oct-2026 until 05-Nov-2026.
Archit Organosys Board Meeting Date
Archit Organosys will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.